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Background. Interspecies interactions of the nasopharyngeal microbiota are likely to be involved in the
pathogenesis of acute otitis media (AOM). Capturing the breadth of microbial interactions requires a detailed
description of the microbiota during health and AOM.
Methods. The nasopharyngeal microbiota of 163 infants with (n 5 153) or without (n 5 10) AOM was
characterized using nasopharyngeal swabs and multiplexed pyrosequencing of 16S rRNA. Nasopharyngeal swab
specimens were collected during 4 winter seasons from 2004 through 2010 for infants with AOM and during 2010
for controls.
Results. Fifty-eight bacterial families were identified, of which Moraxellaceae, Streptococcaceae, and
Pasteurellaceae were the most frequent. Commensal families were less prevalent in infants with AOM than in
controls. In infants with AOM, prior exposure to antimicrobials and administration of the heptavalent conjugated
pneumococcal polysaccharide vaccine (PCV7) were also associated with reduced prevalence of distinct
commensal families (Streptococcaceae and Corynebacteriaceae). In addition, antimicrobial exposure increased
the prevalence of Enterobacteriaceae and the abundance of Pasteurellaceae. Other factors, such as age, sex,
day care, and a history of recurrent AOM, did not influence the microbiota.
Conclusions. Infants’ nasopharyngeal microbiota undergoes significant changes during AOM and after
exposure to antimicrobials and PCV7, which is mainly attributable to reduced prevalence of commensal bacterial
families.
Acute otitis media (AOM) is one of the most common
pediatric infectious diseases worldwide and a major
reason for antibiotic prescription for children in de-
veloped countries [1–3]. The 3 main pathogens as-
sociated with AOM are Streptococcus pneumoniae,
Haemophilus influenzae, and Moraxella catarrhalis [4].
The human nasopharynx is the primary site of colo-
nization for these pathogens, and it is the starting point
for their ascendance to the middle ear. Numerous
bacterial virulence factors have been identified and
strategies used by these pathogens to evade host de-
fense mechanisms have been studied [5]. Less is
known about the role of the microbial community
structure and interspecies interactions for the path-
ogenesis of AOM [6, 7].
Evidence for interspecies cross-talk has recently been
demonstrated by the influence of the heptavalent con-
jugated pneumococcal polysaccharide vaccine (PCV7)
on the colonization prevalence of the AOM pathogens
H. influenzae, M. catarrhalis, and Staphylococcus aureus
[8–10].
To capture the breadth of interspecies interplays,
a detailed description of the microbiota in the healthy
and the disease stage is required. Conventional culture
has limited value for such purpose, because many bac-
teria that colonize humans cannot be cultured [11].
There have been significant developments in applying
cultural-independent methods to characterize microbial
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communities in different human body habitats [12–14], in-
cluding shotgun sequencing of the whole metagenome and
amplicon sequencing of selected phylogenetic markers [15].
In a recent study, microbial communities in the upper re-
spiratory tract of children with or without AOM were de-
scribed [16]. This study included children of a wide age range
spanning from 6 months to 6 years and was based on samples
taken from nostrils. The study presented here focused on
a narrower age range of infants (0–1 year) and applied py-
rosequencing of 16S rRNA gene amplicons to nasopharyngeal
swab (NPS) specimens from infants with AOM and control
infants. The study period spanned the years before and after
introduction of PCV7 in 2006 in Switzerland. The main re-
search aim was to characterize the microbiota in infants with
AOM and to compare it with those in control infants. In
addition, we studied the influence of recent antimicrobial
exposure and administration of PCV7 on the nasopharyngeal
microbiota in infants with AOM. Such data will serve as basis
for further studies on the role of the nasopharyngeal microbiota
in the pathogenesis of AOM.
METHODS
Patients and Sample Collection
NPS specimens were collected in an ongoing nationwide sur-
veillance program from consecutive infants,2 years of age who
presented with AOM in outpatient practice [17]. The study
period included 4 winter seasons: December 2004–February
2005, November 2006–March 2007, November 2007–March
2008, and November 2008–March 2009 [18]. Data on age, sex,
place of residence, antimicrobial treatment during the previous
8 weeks, the number of AOM episodes during the previous
12 months, current use of day care, and vaccination with PCV7
were obtained at the time of sample collection. In Switzerland,
PCV7 was added to the routine vaccination schedule in 2006.
Therefore, season 1 (2004–2005) was designated as the pre-
vaccine season (Table 1). Of a total of 218 NPS specimens
collected during the study period, 153 were selected for this
study. Twenty-five and 40 NPS specimens were excluded be-
cause they did not have sufficient DNA or were lacking clinical
information, respectively.
In addition to the 153 infants with AOM, NPS specimens
were collected from 10 infants without AOM who were seen for
various reasons at the outpatient clinic of the University Hospital
of Berne in 2010 (Table 1). The diagnoses for which control
infants were seen were surgery of the lingual frenulum in 1 infant
and a lymphangioma at the neck in 1 infant. Six and 1 infants
were part of a human immunodeficiency virus (HIV) and hep-
atitis C virus exposure study group, respectively, but were HIV
and hepatitis C virus negative. Finally, 1 infant presented to the
clinic with repeated skin abscesses, but no underlying morbidity
was identified.
Approval from the local ethics committee and informed
consent were obtained for the collection of samples from con-
trols. The surveillance program is part of the governmental
public health surveillance and is exempted from approval by
institutional review boards.
16S rRNA Gene–Specific Polymerase Chain
Reaction
Handling of swabs and DNA extraction has been previously
described [19]. For every 10 samples, we included a negative
mock control for which the extraction protocol was performed
in an identical manner as for the samples. V3–V5 regions of
bacterial 16S rRNA genes were then amplified using the
primer pairs 341F/926R [14]. Primer sequences were modi-
fied by addition of sequencing adaptors A (forward) or B
(reverse) and a 10-mer multiplex identifier (Supplementary
Table 1): A-341F (5#-CGT ATC GCC TCC CTCGCG CCA TCA
G[NNNNNNNNNN]A CTC CTA CGGGAG GCA GCA G-3#)
and B-926R (5#-CTA TGC GCC TTG CCA GCC CGC TCA
G[NNNNNNNNNN]C CGT CAA TTCMTT TGA GTT T-3#).
Table 1. Sociodemographic and Clinical Characteristics of
Study Infants With Acute Otitis Media and Healthy Control Infants
Infants With AOMa Controlsb
Characteristic No. % No. %
Age, y
0 61 40 5 50
1 92 60 3 30
2 0 0 2 20
Sex, female 74 48 6 60
Antibiotic exposurec 39 26 1 10
Day care used 54 35 0 0
Streptococcus pneumoniae
carriagee
80 52 1 10
PCV7 vaccinated 87 57 7 70
Post–vaccine seasonf 122 80 10 100
Past AOM episodesg
#1 episode 118 83 0 0
$2 episodes 25 17 0 0
Abbreviations: AOM, acute otitis media; PCV7, heptavalent conjugated
pneumococcal polysaccharide vaccine.
a General practitioners contributing the 153 nasopharyngeal swabs of infants
with AOM are part of the Swiss Sentinel Surveillance Network [17].
b The 10 control infants were recruited at the outpatient clinic of the University
Hospital of Berne.
c Antibiotic exposure during the 8 wk before swab collection.
d Current day care usage: no information available for 10 samples.
e S. pneumoniae carriage results derived from culture.
f PCV7 was added to the routine vaccine schedule for infants in 2006.
g Number of AOM episodes during the past 12 mo; no information available for
10 samples.
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Polymerase chain reaction (PCR) was performed in a total
volume of 50 lL with use of 13 Fast Start Taq reaction buffer,
2.0 mM (final) magnesium chloride, 0.2 mM (final) de-
oxyribonucleotide triphosphate, 1 lM (final) of forward and
reverse fusion primers, 3 units of Fast Start Taq Polymerase
(Roche), and 10 lL of extracted DNA. PCR cycling conditions
included 95C for 6 minutes; 35 cycles of denaturation at 95C
(30 seconds), annealing at 59C (30 seconds), and elongation
at 71C (2 minutes); and final at 71C for 7 minutes. PCR
products were purified using Wizard SV PCR clean-up system
(Promega). The final elution step was performed using 40 lL
double distilled water.
454 Titanium Amplicon Sequencing
Samples were pooled using 10 ng of PCR product of each
samples, resulting in 16 different pools, including every
multiplex identifier once. The amplification results of the
mock controls were consistently below detection level and
could therefore not have been added to the 454 run. The
amplicon libraries were sequenced according to the 454
Titanium Amplicon Sequencing protocols, and a series of
quality control steps were applied to the resulting 454 reads
(Supplementary Methods). A total of 77 599 forward and
133 761 reverse reads of uniform length of 200 nucleotides
and high quality were retained after filtering and have been
submitted to National Center for Biotechnology Information
Sequence Read Archive (accession number SRA026964.1)
(Supplementary Table 1).
Calculation of Richness and Shannon Diversity Indices and
Community Comparisons (a and b Diversity)
Pyrotagger was used for the definition of operational taxonomic
units (OTUs) based on 97% sequence identity, estimation of
chimeras, and taxonomy assignments [20] (Supplementary
Methods). Outputs were used to create rarefaction curves and
showed flattening of curves after 250 sequences (Supplementary
Figure 1). Alpha diversity analysis (including richness and Shan-
non and Simpson Diversity indices) was performed usingMothur
software [21]. Statistically significant differences were received
using 2-tailed t test or analysis of variance if variables comprised
.3 groups (aov function in R) without excluding outliers.
Differences between relative abundance measures (percent-
age) were assessed by parametric (t test or analysis of variance)
and nonparametric (Mann–Whitney) tests. Fisher exact test was
used for the prevalence analysis of bacterial families (Table 2).
Community comparisons were done using nonmetric multi-
dimensional scaling (nMDS) and the adonis function of the
vegan package in R (Supplementary Methods). The nMDS
analysis is a nonparametric ordination-based method for
reducing ecological community data complexity and identifying
meaningful relationships among communities [22].
RESULTS
Description of Study Patients
Sociodemographic and clinical characteristics of the 153 infants
with AOM and 10 controls included in this study are described
Table 2. Prevalence of Bacterial Families in the Nasopharynx of Infants With Acute Otitis Media and Healthy Controlsa
Infants With AOM, %
Controls Antibiotic Exposure PCV7 Vaccination
Organism No. (%) All No. (%) P Valueb Yes No. (%) No No. (%) P Valueb Yes No. (%) No No. (%) P Valueb
Total number of study infants 10 153 39 114 87 66
Moraxellaceae 9 (90) 145 (95) .4 37 (95) 108 (95) 1 81 (93) 64 (97) .5
Streptococcaceae 9 (90) 113 (74) .5 23 (59) 90 (79) .02 60 (69) 53 (80) .1
Pasteurellaceae 6 (60) 91 (60) 1 27 (69) 64 (56) .2 55 (63) 36 (55) .3
Staphylococcaceae 7 (70) 29 (19) .001 7 (18) 22 (19) 1 16 (18) 13 (20) .8
Corynebacteriaceae 8 (80) 71 (46) .05 9 (23) 62 (54) .001 33 (38) 38 (58) .02
Flavobacteriaceae 7 (70) 24 (16) .0004 10 (26) 14 (12) .07 15 (17) 9 (14) .7
Carnobacteriaceae 5 (50) 25 (16) .02 10 (26) 15 (13) .08 15 (17) 10 (15) .8
Enterobacteriaceae 4 (40) 25 (16) .08 11 (28) 14 (12) .03 17 (20) 8 (12) .3
Comamonadaceae 6 (60) 23 (15) .003 7 (18) 16 (14) .6 16 (18) 7 (11) .3
Streptococcaceae with
S. pneumoniaec
1 (10) 80 (52) .0002 15 (38) 65 (57) .04 47 (54) 33 (50) .048
Streptococcaceae without
S. pneumoniaec
8 (80) 33 (22) 8 (21) 25 (22) 13 (15) 20 (30)
Abbreviations: AOM, acute otitis media; PCV7, heptavalent pneumococcal polysaccharide vaccine; S. pneumoniae, Streptoccocus pneumoniae.
a Presence of a bacterial family was defined as detection of at least 1 sequence attributed to this family.
b Fisher exact test (2 3 2 or 2 3 3) was used as appropriate using absolute sample numbers.
c Presence of S. pneumoniae was based on bacterial culture results [18].
1050 d JID 2012:205 (1 April) d Hilty et al
in Table 1. Male infants predominated slightly. Approximately
one-quarter of infants with AOM had been recently exposed
to antimicrobials, approximately one-third attended day care,
and approximately half had received PCV7. Streptococcus
pneumoniae was detected by culture in more than half of
infants with AOM and in 10% of controls.
Richness and Diversity of Bacterial OTUs
The composition of the microbial communities in each of the
163 samples was determined using bidirectional pyrosequencing
targeting the variable regions 3–5 of the 16S rRNA gene.
Forward sequences were then clustered at 97% sequence
identity to identify OTUs. The median number of OTUs from
infants with AOM (median, 6; range, 1–61) was significantly
lower than for controls (median, 24; range, 2–144; P ,.001).
The median Shannon Diversity indices, which include both
OTU richness and evenness, were 0.69 for infants with AOM
and 1.31 for control infants (P 5 .002). Therefore, in infants
with AOM, microbiota comprised fewer OTUs and OTUs were
less evenly distributed than in controls.
Prevalence of Bacterial Families
OTUs were grouped into 58 bacterial families, of which
Moraxellaceae (present in 154 of 163 NPS specimens),
Streptococcaceae (122 of 163), and Pasteurellaceae (97 of 163)
were most frequent (Table 2). Putative commensal families
were more frequent in controls than in infants with AOM.
These included Staphylococcaceae (Fisher exact test, P5 .001),
Flavobacteriaceae (P 5 .0004), Carnobacteriaceae (P 5 .02),
and Comamonadaceae (P 5 .003). Infants with AOM who
were recently exposed to antimicrobials less frequently carried
Streptococcaceae (P5 .02) and Corynebacteriaceae (P5 .001),
but more frequently carried Enterobacteriaceae (P 5 .03) than
did those without such exposure. In addition, infants with
AOM who had received at least 1 dose of PCV7 less frequently
carried Corynebacteriaceae (P 5 .02) than did nonvaccinated
infants. A map showing the prevalence of all bacterial families is
available (Supplementary Figure 2).
More-detailed analysis of Streptococcaceae was hampered
by the fact that 16S sequencing does not discriminate in this
family when using a cutoff of 97%. Therefore, culture results
for S. pneumoniae were included (Table 2). Most controls
(80%) but only approximately one-fifth (21.5%) of infants with
AOM had a culture negative for S. pneumoniae but carried
other Streptococcaceae (P 5 .0002). Recent exposure to anti-
microbials was associated with a lower prevalence of carriage of
Streptococcaceae, including S. pneumoniae (P 5 .04). Receipt
of PCV7 was associated with reduced prevalence of non-
pneumococcal Streptococcaceae (P 5 .048).
Relative Abundance of Bacterial Families
Next, the relative abundance of bacterial families in each sample
was determined and means (6 standard error of the mean) were
calculated and compared between infants with AOM and con-
trols, infants with AOMwho had been exposed to antimicrobials
or not, and those who had received PCV7 or not (Figure 1A, 1B,
and 1C). Moraxellaceae, Streptococcaceae, and Pasteurellaceae
tended to be more abundant in infants with AOM than in
controls, although these differences did not reach statistical
Figure 1. Relative abundance of bacterial families (mean and standard
error of the mean) with an abundance of.2% are shown for infants with
acute otitis media (AOM; A ), compared with controls, in infants with
AOM according to recent antibiotic exposure (B ), and the vaccination
status for the 7-valent conjugated polysaccharide vaccine (PCV7; C ).
P values derived by Student t test are indicated.
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significance (Figure 1A). Only Staphylococcaceae were more
abundant in controls than in infants with AOM (P5 .0001). Of
the bacterial families classified as others, none reached an
abundance of .2% in infants with AOM. In the healthy
controls, the other families reaching an abundance of .2.0%
included Comamonadaceae (4.8%, mainly Comamonas spe-
cies), Acidaminococcaceae (3.5%, mainly Veillonella species),
Enterococcaceae (3.4%, mainly Enterococcus species), Carno-
bacteriaceae (2.9%, mainly Granulicatella species), and Neis-
seriaceae (2.6%, mainly Neisseria species).
Use of the Mann–Whitney U test revealed statistically sig-
nificant differences among Staphylococcaceae (P 5 .003),
Comamonadaceae (P5 .04), Acidaminococcaceae (P5 .003),
and Corynebacteriaceae (P 5 .04). This is comparable to the
prevalence analysis (Table 2).
Recent exposure to antimicrobials was associated with an
increased abundance of Pasteurellaceae (P 5 .0048). Further-
more, nonsignificant trends for a lower relative abundance of
Moraxellaceae, Streptococcaceae, and Staphylococcaceae were
noted in the antimicrobial exposure group (Figure 1B). Ad-
ministration of PCV7 was not associated with a significant
increase or decrease in the abundance of bacterial families
(Figure 1C).
Microbial Community Comparisons
To further evaluate the influence of clinical factors, pairwise
distances between microbial communities per sample were
measured. Prevalence-based (unweighted) and abundance-
based (weighted) distance matrices were used as input, and
the amount of variance that each clinical variable (AOM, anti-
microbial exposure, and administration of PCV7) contributed
was calculated.
In the unweighted analysis, the nasopharyngeal bacterial
communities of controls and infants with AOM differed sig-
nificantly from each other (P , .005) (Figure 2A). To exclude
a selection bias by time, this analysis was also performed after
excluding all samples collected in the prevaccine season, but
a similar difference was received (P , .05; data not shown).
Recent exposure to antimicrobials had the strongest influence
on the microbiota of infants with AOM (P, .005) (Figure 2B).
In addition, administration of PCV7 (P, .05) (Figure 2C) and
sampling in the prevaccine versus postvaccine season (P , .05;
data not shown) had a slight but statistically significant in-
fluence on the microbial community. Factorial analysis of
variance showed that the antimicrobials and PCV7 acted in-
dependently from each other. Furthermore, age, sex, number of
AOM episodes during the previous 12 months and day care use
had no influence in the univariate analysis (Supplementary
Table 2). Use of weighted distance matrices again revealed
a significant difference between infants with AOM and controls
(P , .05), but for none of the other factors studied (not
shown). This indicates that differences between microbiota
were based more on discrepancies related to prevalence of
bacterial families (unweighted analysis) than on their relative
abundance (weighted analysis).
Colonization Density
Colonization density was estimated by measuring the DNA
concentration of the PCR amplification product. Significantly
lower DNA quantities were observed in the nasopharynx of
controls (median value, 12 ng/lL), compared with infants with
AOM (38 ng/lL; P 5 .005). In addition, DNA quantities were
lower in microbial communities containing no S. pneumoniae
but other Streptococcaceae (32 ng/lL), compared with those
with a culture positive for S. pneumoniae (39 ng/lL) and those
without any Streptococcaceae (42 ng/lL; P 5 .048). These
results suggest an inverse relationship between colonization
density and OTU richness. No statistically significant differences
Figure 2. Comparison of bacterial communities by nonmetric multidi-
mensional scaling (nMDS) ordination plots. Shown are the results for
infants with acute otitis media (AOM), compared with control infants
(A), infants with AOM with or without recent antibiotic exposure (B ), and
receipt or not of the 7-valent conjugated polysaccharide vaccine (PCV7;
C ). Unweighted unifrac distance matrices were used as input, and each
data point in the nMDS plot represents the bacterial community identified
from a single nasopharyngeal sample. Comparison using F tests using the
adonis function of the vegan package yielded the F values for A, 9.5
(P , .005); for B, 9.9 (P , .005); and for C, 5.4 (P , .05). P values are not
shown as absolute values, because multiple calculations yielded slight
variations
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were found when stratifying DNA concentrations for the
clinical variables age, sex, recent antibiotic exposure, and PCV7
vaccination.
DISCUSSION
This study used high-throughput sequencing for the analysis
of the nasopharyngeal microbiota in infants with AOM and
control infants, taking into account additional host factors,
such as prior exposure to antimicrobials and PCV7 vaccina-
tion status. Strengths of this analysis are a homogeneous study
population restricted to infants ,2 years of age, sampling
from the nasopharynx, a large sample size, and the possibility
to study the influence of clinical variables.
Microbial community comparisons showed statistically
significant differences between infants with AOM and control
infants. The healthy infant microbiota was characterized by
the presence of low prevalent bacterial families and non-
pneumococcal Streptococcaceae. In infants with AOM, how-
ever, the classical AOM pathogens predominated over rare,
putative commensal bacterial families. This finding is in line
with previous reports using culture- and nonculture- based
methods to examine the respiratory tract microbiota [16, 23].
They suggest that a richer and more diverse microbiota may
protect against AOM. This is supported by reports about an
inhibitory effect of a-hemolytic streptococci on colonization
with AOM pathogens and, thereby, protection against re-
currence of AOM [24, 25]. Little is known about the epide-
miology and biology of the low prevalent bacterial families
living in the nasopharynx, apart from being involved in iso-
lated cases of AOM, opportunistic infections, or bloodstream
infections associated with dental procedures [26–28].
A recent study investigated the microbiota in healthy infants
18 months of age during the winter and the summer season [29].
Comparable to the controls in our study, a complex, diverse,
and highly variable microbiota was found with relatively lower
proportions of the 3 AOM pathogens (Moraxellaceae, Strep-
tococcaceae, and Pasteurellaceae), compared with our infants
with AOM. This confirms the validity of our control group and
shows that, independent of the geographical site, the same
bacterial families are residing in the nasopharynx of infants.
The modulating effect of antibiotic exposure on the human
microbial ecosystem has been well recognized [30]. In this study,
recent antimicrobial treatment was the strongest factor inducing
bacterial community changes in the nasopharyngeal microbiota
in infants with AOM. Community structure changed toward
reduced prevalence of commensal families (Streptococcaceae,
including pneumococci and Corynebacteriaceae), increased
prevalence of Enterobacteriaceae, and greater relative abun-
dance of Pasteurellaceae. The latter observation has been re-
ported also in earlier culture-based studies [31, 32]. Therefore,
antimicrobials change the microbiota toward an unhealthy
status with lesser presence of commensals. In general, effects
of antibiotic exposure on the microbiota can be expected to
depend largely on the prevalence of resistance genes. They
may therefore overrule interspecies relationships and may lead
to complex and unpredictable changes of the microbiota.
Broad use of PCV7 has been paralleled by shifts of pneu-
mococcal serotype distribution and, unexpectedly, changes in
the prevalence of pathogens residing in the nasopharynx on an
individual and population level [10]. In our study, having
received vaccination with PCV7 and having had samples ob-
tained after the introduction of PCV7 changed the commu-
nity structure of the microbiota toward reduced prevalence of
commensals (Streptococcaceae excluding pneumococci and
Corynebacteriaceae). Therefore, unexpectedly, the results in-
dicate that PCV7 drives the microbiotia toward a composition
with lower presence of commensals. The mechanisms mediat-
ing the influence of PCV7 are not clear, but it may be that
pneumococcal serotypes that have emerged under the selection
pressure of PCV7 inhibit colonization by commensal Strepto-
coccaceae more than the PCV7 serotypes did.
In this study, no influence of age, history of recurrent AOM,
sex, or day care use on the microbiota was observed in infants
with AOM. The lack of an association with age can be explained
by the narrow age range studied. Sociodemographic differences
between Switzerland and other countries may be the reason
that day care had no measurable influence on the microbiota.
A potentially important factor could be concurrent infection
with a respiratory virus. In a preliminary study, we analyzed
81 samples from infants with AOM collected from 2004
through 2006 for the presence of RNA viruses, including
human rhinovirus, respiratory syncytial virus, coronavirus,
and bocavirus. The presence of any of these viruses did not
have an effect on the microbiota, either on the prevalence or
the abundance of bacterial families (data not presented). In
agreement with our preliminary data, no evidence for an as-
sociation between seasonal shifts in microbiota and the pres-
ence of respiratory viruses was found in healthy infants in the
Netherlands [29]. However, additional studies are needed to
explore the role of viruses in the microbiota in more detail.
Our study has limitations. Samples from infants with AOM
were restricted to those collected during winter seasons be-
cause AOM incidence peaks during winter, and there was no
information about diet, number of siblings, or parental
smoking, which may all have an influence on the microbiota.
The results from our study may therefore not apply to the
summer season, as has been shown for healthy controls [29].
The number of controls was small, and samples were collected
during a relatively short period after the introduction of PCV7
in a selected geographic region, compared with samples for
infants with AOM. However, the results obtained for our
control infants resembled closely those described in a recent
Dutch study, as discussed above [29]. Another limitation of
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our study is the lack of high-quality quantitative data on col-
onization density, because the quantity of bacterial DNA in
NPS specimens is very small, which impedes a reliable
quantification of the microbiota directly in the sample.
However, taking the DNA concentration of the PCR ampli-
fication product as a surrogate for colonization density has
been described as a reasonable approach [18]. Our results
suggest that colonization density is lower in bacterial com-
munities of increased richness, such as the healthy micro-
biota in the controls. Increased quantities of nontypeable
H. influenzae, S. pneumoniae, and M. catarrhalis have been
observed in nasopharyngeal secretions during AOM, com-
pared with the healthy status [33]. Therefore, the patho-
genesis of AOMmay include a disturbance of the interspecies
balance with ensuing overgrowth of an AOM pathogen.
In conclusion, our study is the first to characterize the
nasopharyngeal microbiota of infants with and without AOM
with use of molecular techniques. Key findings are the char-
acterization of the microbiota in infants with AOM as a flora
of reduced richness and evenness, but higher colonization
density, compared with healthy controls. In infants with AOM,
recent antimicrobial exposure and PCV7 influenced commu-
nity structure of the microbiotia toward lower prevalence of
commensal bacterial families (especially Streptococcaceae and
Corynebacteriaceae).
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